Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the Prolia Risk Evaluation and Mitigation of Strategy (REMS) (20240121)

12/12/2024
11/02/2026
EU PAS number:
EUPAS1000000393
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Updated protocol

Protocol-Published Amendment denosumab 20240121 1.pdf

First published: 13/02/2025
English (2.37 MB - PDF) View document
Study results
Study report
Other information